Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HULC-2: UC-MSCs for BPD Prevention
NCT07058025Phase 2Not yet recruiting
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Oct 2025
- Primary completion
- Sep 2028
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in bronchopulmonary dysplasia (BPD), sponsored by Ottawa Hospital Research Institute. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT07058025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07058025.